In ER-positive breast cancer patients, high membrane S1PR1 expression was associated with shorter time to recurrence, whilst high cytoplasmic S1PR1 was correlated with shorter disease-specific survival times [28], suggesting a cancer promoting role of S1PR1 subtype. Here, S1PR1 is linked to cancer.